As such, the sex-specific molecular mechanisms of regulation for the HGD and the sEH inhibitor identified in this study may provide future therapeutic molecular targets for the hyperglycemia-induced microvascular dysfunction associated with dementia, diabetes, and cardiovascular diseases. This evidence concerns the gene EPHX2 and diabetes mellitus.